| Sandra Weimert, CRNA | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-0999 | |
| (734) 936-4280 | |
| Not Available |
| Full Name | Sandra Weimert |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063450153 | NPI | - | NPPES |
| 4142247 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 4704103254 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Weimert, CRNA 3621 S State St, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | Sandra Weimert, CRNA 1500 E Medical Center Dr, Ann Arbor, MI 48109-0999 Ph: (734) 936-4280 |
News Archive
The effectiveness of chemotherapy in patients with advanced breast cancer can be evaluated earlier by using 18F-FDG positron emission tomography (PET) imaging over other conventional imaging procedures, according to an article in the July issue of the Society of Nuclear Medicine's Journal of Nuclear Medicine.
Targeted Medical Pharma, today announced the completion of an agreement between Analytical Testing Laboratories (ATL), a Lebanon based company that specializes in drug testing services and inborn errors of metabolism, for the exclusive distribution of the company's amino acid based products to physicians and pharmacies throughout the Middle East.
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
DNA testing company 23andMe will soon release a DNA test that can predict an individuals' risk of developing type 2 diabetes, but many experts are concerned.
The U.S. Food and Drug Administration today issued guidance on Bayesian statistical methods in the design and analysis of medical device clinical trials that could result in less costly and more efficient patient studies.
› Verified 7 days ago
Denise Lynn Berry, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Ashley Marie Dibardino, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Terrance Solan, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Paula K Globerson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Lawrence R Stump, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Mary Catherine Downey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Renee Ann Shea, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Drive, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 |